Login / Signup

Determinants of treatment in patients with stage IV renal cell carcinoma.

Christopher S HollenbeakEric W SchaeferJustin DoanJay D Raman
Published in: BMC urology (2019)
Elderly patients with metastatic RCC present a unique subpopulation for consideration owing to competing causes of mortality. Many elderly patients with stage IV RCC did not receive surgery or systemic therapy up to 6 months from diagnosis. Several clinical and demographic factors were associated with this observation. Further investigation is needed to understand the rationale underlying the underutilization of systemic therapy in elderly patients.
Keyphrases
  • renal cell carcinoma
  • middle aged
  • minimally invasive
  • clinical trial
  • community dwelling
  • cardiovascular disease
  • acute coronary syndrome
  • atrial fibrillation
  • replacement therapy